IRIS
FALASCA, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.243
AS - Asia 4.878
EU - Europa 4.609
SA - Sud America 793
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 17.615
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.084
SG - Singapore 1.976
CN - Cina 1.234
IT - Italia 834
IE - Irlanda 679
BR - Brasile 623
RU - Federazione Russa 589
VN - Vietnam 540
SE - Svezia 531
UA - Ucraina 522
GB - Regno Unito 374
DE - Germania 373
TR - Turchia 369
FR - Francia 254
IN - India 212
FI - Finlandia 191
HK - Hong Kong 118
BD - Bangladesh 104
KR - Corea 94
CA - Canada 84
AR - Argentina 80
AT - Austria 44
NL - Olanda 44
MX - Messico 41
PL - Polonia 34
JP - Giappone 32
ID - Indonesia 29
IQ - Iraq 28
ES - Italia 26
EC - Ecuador 25
ZA - Sudafrica 23
PH - Filippine 21
PK - Pakistan 21
BE - Belgio 18
CZ - Repubblica Ceca 17
SA - Arabia Saudita 16
CO - Colombia 15
RO - Romania 15
KE - Kenya 13
CH - Svizzera 12
LT - Lituania 12
PY - Paraguay 12
VE - Venezuela 12
CL - Cile 9
EG - Egitto 9
JO - Giordania 9
TN - Tunisia 9
NP - Nepal 8
PS - Palestinian Territory 8
UY - Uruguay 8
MY - Malesia 7
PE - Perù 7
UZ - Uzbekistan 7
BG - Bulgaria 6
IL - Israele 6
JM - Giamaica 6
MA - Marocco 6
AU - Australia 5
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
HR - Croazia 5
TW - Taiwan 5
CI - Costa d'Avorio 4
EE - Estonia 4
EU - Europa 4
HN - Honduras 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BB - Barbados 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
PA - Panama 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CY - Cipro 1
Totale 17.600
Salva come PNG Salva come JPEG
Città #
Singapore 1.459
San Jose 887
Chandler 780
Jacksonville 696
Dublin 662
Dallas 545
Ashburn 512
Princeton 318
Beijing 296
Southend 244
Nanjing 215
Izmir 195
Santa Clara 172
Ho Chi Minh City 169
The Dalles 166
Los Angeles 161
Council Bluffs 148
Altamura 141
Hanoi 133
Munich 126
Chieti 111
Dearborn 108
New York 107
Wilmington 104
Hong Kong 103
Cambridge 97
Ann Arbor 87
Tongling 82
Boardman 76
Buffalo 71
Redondo Beach 69
São Paulo 68
Nanchang 65
Moscow 59
Pescara 58
Orem 48
Helsinki 46
Rome 41
Nuremberg 38
Brooklyn 37
Shenyang 37
Milan 35
Seattle 34
Turku 34
Pune 33
Tokyo 31
Denver 30
Dong Ket 30
Frankfurt am Main 30
Warsaw 30
Washington 29
Tianjin 28
Toronto 28
Chennai 27
Hebei 27
Haiphong 26
Hefei 26
Jiaxing 25
Atlanta 24
Chicago 24
Da Nang 24
Kunming 24
Montreal 24
Rio de Janeiro 24
Woodbridge 24
Hangzhou 22
London 21
Mexico City 21
Changsha 20
Manchester 20
Houston 19
Phoenix 19
Stockholm 19
Brussels 17
Mumbai 17
Grevenbroich 16
Norwalk 16
San Francisco 16
Brasília 15
Baghdad 14
Curitiba 14
Jinan 14
Johannesburg 14
Salvador 14
Vienna 14
Augusta 13
Boston 13
Changchun 13
Espoo 13
Hải Dương 12
Jeddah 12
Nairobi 12
Poplar 12
Brno 11
Shanghai 11
St Louis 11
Biên Hòa 10
Guangzhou 10
Guarulhos 10
Jakarta 10
Totale 10.723
Salva come PNG Salva come JPEG
Nome #
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 180
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 178
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 176
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 171
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 171
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 171
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 168
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 164
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 162
Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features 160
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 159
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 159
Acute urinary retention due to HSV-1: a case report 158
Metabolic modifications in HIV-infected women 152
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 150
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 146
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 146
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 145
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 144
Canakinumab in a subgroup of patients with COVID-19 141
Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacy 139
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 138
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 137
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 137
Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19 135
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 135
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 133
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study 133
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 133
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 133
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 132
Antiretroviral therapy management and rationalisation of available resources 129
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 128
Relevance of plant lectins in human cell biology and immunology 128
Is the rate of virological failure to cART continuing to decline in recent calendar years? 127
Assessment of the Vanillin Anti-Inflammatory and Regenerative Potentials in Inflamed Primary Human Gingival Fibroblast 127
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 126
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 126
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 126
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 123
Different strategies of 25OH vitamin D supplementation in HIV+ subjects. 123
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 123
Normal breathing releases SARS-CoV-2 into the air 123
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 122
Associations between immune depression and cardiovascular events in HIV infection. 122
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV 122
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 121
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 120
Inguinal lymphadenopathy due to Bartonella henselae 120
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 120
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 120
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 120
New Therapeutic Options in Mild Moderate COVID-19 Outpatients 119
Antimicrobial resistance in intensive care patients hospitalized with SEPSIS: a comparison between the COVID-19 pandemic and pre-pandemic era 119
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 119
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 117
Clinical characteristics and cardiovascular implications of the dead patients for COVID-19 117
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study 116
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 115
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 114
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 114
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 114
Periodontitis and cytokine patterns in HIV positive patients 113
IL-1beta induces alkaline phosphatase in human phagocytes 112
High dose of erythropoietin in management of interferon/ribavirin induced anemia 111
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 111
Proteinuria in an African HIV-infected patient: effects of telmisartan. 111
Neuroprotective Potential of Bacopa monnieri: Modulation of Inflammatory Signals 111
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 109
Approach to COVID-19 in older adults and indications for improving the outcomes 109
Early detection of pleuro-pulmonary tuberculosis by bedside lung ultrasound: A case report and review of literature 108
Hypertension in HIV: Management and Treatment 108
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? 107
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study 107
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 106
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 106
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study. 105
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 105
Interleukin-31: a new cytokine involved in inflammation of the skin 104
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 104
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. 104
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 104
Evaluation of Cell Migration and Cytokines Expression Changes under the Radiofrequency Electromagnetic Field on Wound Healing In Vitro Model 104
Correlation between neurocognitive disorders and pattern cytokines in HIV+ patients 103
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 103
First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 103
Pidotimod and Immunological Activation in Individuals Infected with HIV 103
Are monoclonal antibodies effective in patients with severe obesity in SARS‐CoV‐2 infected? 102
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 102
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity 102
Severe HIV-associated hypertriglyceridemia treated with rosuvastatin plus mega-3 fatty acids 102
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. 102
Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. 102
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 102
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 102
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men 101
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 101
Infected atrial mixoma: a rare cause of fever 100
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 100
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. 100
Totale 12.435
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.061
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 0 0 69
2021/2022773 27 24 11 157 46 17 30 57 57 28 80 239
2022/20232.316 208 360 139 241 205 439 131 174 252 27 67 73
2023/20241.157 76 50 84 42 100 326 262 58 9 19 12 119
2024/20252.970 187 528 383 112 60 134 97 183 267 209 336 474
2025/20266.802 470 251 876 897 590 370 1.115 405 670 646 363 149
Totale 18.408